Prime Synthesis, Inc. Establishes 3-Prime Division To Deliver Customized Products For Research And Diagnostic Synthesis Markets

ASTON, Pa.--(BUSINESS WIRE)--July 13, 2006--Prime Synthesis, Inc. a key developer of DNA synthesis support products for life sciences research worldwide, announces the creation of 3-Prime, llc. its newest production and distribution division. Established to serve the evolving needs of oligonucleotide researchers in the R&D synthesis markets, 3-Prime, will service the nucleic acid synthesis needs of a wide range of researchers and companies.

MORE ON THIS TOPIC